Litcius/Paper detail

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, Richard Whitlock, Sumathy Rangarajan, Lizhen Xu, Laura Heenan, Shrikant I. Bangdiwala, Wadea Tarhuni, Mohamed Hassany, А. V. Kontsevaya, William Harper, Sanjib Kumar Sharma, Patricio López‐Jaramillo, Antonio L Dans, Lia M. Palileo‐Villanueva, Álvaro Avezum, Prem Pais, Denis Xavier, Camilo Félix, Afzalhussein Yusufali, Renato D. Lópes, Otávio Berwanger, Zeeshan Ali, Sean Wasserman, Sonia S. Anand, Jackie Bosch, Shurjeel Choudhri, Michael E. Farkouh, Mark Loeb, Salim Yusuf

2022The Lancet Respiratory Medicine24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAspirinRandomized controlled trialPopulationInternal medicineClinical trialIntention-to-treat analysisPhysical therapyEnvironmental healthCOVID-19 Clinical Research StudiesInflammasome and immune disordersDermatological and COVID-19 studies